EDTUTC-4 New YorkLog in Sign up

ARWR
Arrowhead Research Corporation
stockNASDAQ

At CloseOct 21, 2026 3:59:59 PM EDT

58.83USD-0.144%(-0.09)1,371,453

Pre-marketOct 21, 2026 9:29:30 AM EDT

59.50USD+0.984%(+0.58)

ARWR News

Day breaks

05:21 PM EDTIonis upgraded at BMO on Tryngolza adoption for severe hypertriglyceridemia ·

Seeking Alpha

03:08 PM EDTARWR: Interim ARO-MAPT Data Shows Potential for TRiM™ Platform in CNS Diseases ·

Zacks Small Cap Research

08:44 PM EDTArrowhead Pharmaceuticals, Inc. (ARWR) Discusses ARO-MAPT Interim Results and TRiM CNS Delivery Platform in Investigational CNS Pipeline Transcript ·

Seeking Alpha

08:44 AM EDTArrowhead spikes after early-stage trial data for Alzheimer’s disease ·

Seeking Alpha

07:30 AM EDTArrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers ·

Business Wire

03:00 PM EDTCatalyst watch: Big bank earnings, CPI, and the Paris Auto Show ·

Seeking Alpha

11:59 AM EDTThese healthcare stocks stand out with A+ growth grades ·

Seeking Alpha

07:44 AM EDTThese ten healthcare stocks posted the biggest one-month losses ·

Seeking Alpha

12:01 PM EDTArrowhead Pharmaceuticals, Inc. (ARWR) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript ·

Seeking Alpha

02:11 PM EDTArrowhead Pharmaceuticals, Inc. (ARWR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha